These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1240562)
1. [World survey on the use of thalidomide in leprosy reaction]. Sheskin J; Sagher F Med Cutan Ibero Lat Am; 1975; 3(1):81-3. PubMed ID: 1240562 [TBL] [Abstract][Full Text] [Related]
2. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients. Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496 [TBL] [Abstract][Full Text] [Related]
3. Thalidomide in leprosy--study of 94 cases. Parikh DA; Ganapati R; Revankar CR Indian J Lepr; 1986; 58(4):560-6. PubMed ID: 3572098 [TBL] [Abstract][Full Text] [Related]
4. WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Iyer CG; Languillon J; Ramanujam K; Tarabini-Castellani G; De las Aguas JT; Bechelli LM; Uemura K; Martinez Dominguez V; Sundaresan T Bull World Health Organ; 1971; 45(6):719-32. PubMed ID: 4947831 [TBL] [Abstract][Full Text] [Related]
5. Thalidomide in type-2 lepra reaction--a clinical experience. Jadhav VH; Patki AH; Mehta JM Indian J Lepr; 1990; 62(3):316-20. PubMed ID: 2262716 [TBL] [Abstract][Full Text] [Related]
6. [Motor-conduction velocity of cubital nerves in patients with leprosy reactions. Summary of a 13-year observation series during thalidomide therapy]. Sheskin J; Yaar I Hautarzt; 1979 Jul; 30(7):376-9. PubMed ID: 478858 [TBL] [Abstract][Full Text] [Related]
7. Results of a double blind study of the influence of thalidomide on the lepra reaction. Sheskin J; Convit J Int J Lepr Other Mycobact Dis; 1969; 37(2):135-46. PubMed ID: 4900407 [No Abstract] [Full Text] [Related]
8. The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide. Sheskin J Int J Dermatol; 1980; 19(6):318-22. PubMed ID: 7005131 [No Abstract] [Full Text] [Related]
9. Thalidomide--effect on T cell subsets as a possible mechanism of action. Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920 [TBL] [Abstract][Full Text] [Related]
10. [Experiences with thalidomide in 2 patients with acute lepromatous leprosy reactions]. Hogerzeil LM; Simons RD Ned Tijdschr Geneeskd; 1966 Sep; 110(39):1722-3. PubMed ID: 5977696 [No Abstract] [Full Text] [Related]
11. [Current state of thalidomide treatment of leprosy and leprosy reaction]. Sheskin J; Sagher F Arch Klin Exp Dermatol; 1970; 237(1):312-6. PubMed ID: 4906813 [No Abstract] [Full Text] [Related]
12. Thalidomide in the treatment of lepra reactions. De las Aguas JT Int J Lepr Other Mycobact Dis; 1971; 39(2):593-7. PubMed ID: 4948095 [No Abstract] [Full Text] [Related]
13. A trial of thalidomide in progressive lepra reactions. Cazort RJ; Ye Kun Song Curr Ther Res Clin Exp; 1966 Jun; 8(6):299-311. PubMed ID: 4956514 [No Abstract] [Full Text] [Related]
14. An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug. Iyer CG; Ramu G Lepr India; 1976 Oct; 48(4 Suppl):690-4. PubMed ID: 1026805 [No Abstract] [Full Text] [Related]
15. [Therapeutic experience on the effect of thalidomidomide on lepra reaction]. Sheskin J Hautarzt; 1975 Jan; 26(1):1-5. PubMed ID: 1090562 [No Abstract] [Full Text] [Related]
16. Further observation with thalidomide in lepra reactions. Sheskin J Lepr Rev; 1965 Oct; 36(4):183-7. PubMed ID: 5871249 [No Abstract] [Full Text] [Related]
17. Reactions and their management. Ganapati R; Pai VV J Indian Med Assoc; 2004 Dec; 102(12):688-90, 692, 694. PubMed ID: 15871353 [TBL] [Abstract][Full Text] [Related]
18. Thalidomide. Med Lett Drugs Ther; 1998 Oct; 40(1038):103-4. PubMed ID: 9813597 [No Abstract] [Full Text] [Related]